1. Executive Summary 2. Tofacitinib Market Characteristics
3. Tofacitinib Market Trends And Strategies
4. Tofacitinib Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market
5. Global Tofacitinib Growth Analysis And Strategic Analysis Framework
5.1. Global Tofacitinib PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Tofacitinib Market Growth Rate Analysis
5.4. Global Tofacitinib Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Tofacitinib Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Tofacitinib Total Addressable Market (TAM)
6. Tofacitinib Market Segmentation
6.1. Global Tofacitinib Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antirheumatic
Janus Kinase Inhibitor
Immunosuppressant
6.2. Global Tofacitinib Market, Segmentation By Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
5mg
10mg
11mg
22mg
6.3. Global Tofacitinib Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Other Routes Of Administration
6.4. Global Tofacitinib Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
6.5. Global Tofacitinib Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Ulcerative Colitis
Rheumatoid Arthritis
Psoriasis
Other Applications
6.6. Global Tofacitinib Market, Sub-Segmentation Of Antirheumatic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Conventional Synthetic Antirheumatics
Targeted Synthetic Antirheumatics
6.7. Global Tofacitinib Market, Sub-Segmentation Of Janus Kinase Inhibitor, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
JAK1 Inhibitors
JAK2 Inhibitors
JAK3 Inhibitors
6.8. Global Tofacitinib Market, Sub-Segmentation Of Immunosuppressant, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Corticosteroids
Non-Steroidal Immunosuppressants
7. Tofacitinib Market Regional And Country Analysis
7.1. Global Tofacitinib Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Tofacitinib Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Tofacitinib Market
8.1. Asia-Pacific Tofacitinib Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Tofacitinib Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Tofacitinib Market, Segmentation By Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Tofacitinib Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Tofacitinib Market
9.1. China Tofacitinib Market Overview
9.2. China Tofacitinib Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Tofacitinib Market, Segmentation By Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Tofacitinib Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Tofacitinib Market
10.1. India Tofacitinib Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Tofacitinib Market, Segmentation By Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Tofacitinib Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Tofacitinib Market
11.1. Japan Tofacitinib Market Overview
11.2. Japan Tofacitinib Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Tofacitinib Market, Segmentation By Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Tofacitinib Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Tofacitinib Market
12.1. Australia Tofacitinib Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Tofacitinib Market, Segmentation By Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Tofacitinib Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Tofacitinib Market
13.1. Indonesia Tofacitinib Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Tofacitinib Market, Segmentation By Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Tofacitinib Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Tofacitinib Market
14.1. South Korea Tofacitinib Market Overview
14.2. South Korea Tofacitinib Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Tofacitinib Market, Segmentation By Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Tofacitinib Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Tofacitinib Market
15.1. Western Europe Tofacitinib Market Overview
15.2. Western Europe Tofacitinib Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Tofacitinib Market, Segmentation By Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Tofacitinib Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Tofacitinib Market
16.1. UK Tofacitinib Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Tofacitinib Market, Segmentation By Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Tofacitinib Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Tofacitinib Market
17.1. Germany Tofacitinib Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Tofacitinib Market, Segmentation By Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Tofacitinib Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Tofacitinib Market
18.1. France Tofacitinib Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Tofacitinib Market, Segmentation By Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Tofacitinib Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Tofacitinib Market
19.1. Italy Tofacitinib Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Tofacitinib Market, Segmentation By Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Tofacitinib Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Tofacitinib Market
20.1. Spain Tofacitinib Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Tofacitinib Market, Segmentation By Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Tofacitinib Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Tofacitinib Market
21.1. Eastern Europe Tofacitinib Market Overview
21.2. Eastern Europe Tofacitinib Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Tofacitinib Market, Segmentation By Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Tofacitinib Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Tofacitinib Market
22.1. Russia Tofacitinib Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Tofacitinib Market, Segmentation By Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Tofacitinib Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Tofacitinib Market
23.1. North America Tofacitinib Market Overview
23.2. North America Tofacitinib Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Tofacitinib Market, Segmentation By Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Tofacitinib Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Tofacitinib Market
24.1. USA Tofacitinib Market Overview
24.2. USA Tofacitinib Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Tofacitinib Market, Segmentation By Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Tofacitinib Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Tofacitinib Market
25.1. Canada Tofacitinib Market Overview
25.2. Canada Tofacitinib Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Tofacitinib Market, Segmentation By Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Tofacitinib Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Tofacitinib Market
26.1. South America Tofacitinib Market Overview
26.2. South America Tofacitinib Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Tofacitinib Market, Segmentation By Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Tofacitinib Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Tofacitinib Market
27.1. Brazil Tofacitinib Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Tofacitinib Market, Segmentation By Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Tofacitinib Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Tofacitinib Market
28.1. Middle East Tofacitinib Market Overview
28.2. Middle East Tofacitinib Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Tofacitinib Market, Segmentation By Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Tofacitinib Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Tofacitinib Market
29.1. Africa Tofacitinib Market Overview
29.2. Africa Tofacitinib Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Tofacitinib Market, Segmentation By Strength, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Tofacitinib Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Tofacitinib Market Competitive Landscape And Company Profiles
30.1. Tofacitinib Market Competitive Landscape
30.2. Tofacitinib Market Company Profiles
30.2.1. Beacon Pharmaceuticals Limited Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Globe Pharmaceuticals Ltd. Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Drug International Limited Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Dolphin Pharmaceuticals Overview, Products and Services, Strategy and Financial Analysis
31. Tofacitinib Market Other Major And Innovative Companies
31.1. Lancer Therapeutics
31.2. Glenmark Pharmaceuticals LTD.
31.3. Sun Pharmaceutical Industries Ltd.
31.4. Shandong Octagon Chemicals Limited
31.5. Zydus Lifesciences Ltd.
31.6. Esteve Pharmaceuticals SA
31.7. Unichem Laboratories
31.8. Beijing Mesochem Technology Co. Ltd
31.9. Aprazer Healthcare Pvt Ltd
31.10. Apino Pharma Co Ltd
31.11. Delta Pharma Limited
31.12. Mediconlife
31.13. Sandoz International GmbH
31.14. Mylan N.V.
31.15. Hetero Drugs Limited
32. Global Tofacitinib Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Tofacitinib Market
34. Recent Developments In The Tofacitinib Market
35. Tofacitinib Market High Potential Countries, Segments and Strategies
35.1 Tofacitinib Market In 2029 - Countries Offering Most New Opportunities
35.2 Tofacitinib Market In 2029 - Segments Offering Most New Opportunities
35.3 Tofacitinib Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer